Stemline Therapeutics Inc. (STML) Declined -5.89% or -0.61 To Price $9.74 On Thursday


Stemline Therapeutics Inc. (STML) declined -5.89% or -0.61 to $9.74. It is close to 53371 shares traded, which is 9.17% compare to the average total volume 581816. The market cap of STML is $309.74 million. The year to date change is -1.03%. The 52 week price range is from $7.82 to $20.55. Price of STML have changed 10.46% during last week. It have changed 0.00% over last month, -39.69% over last 3 months, -39.30% over last 6 months and -25.54% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for STML is 11.61. It is 19.20% above current price. The 200-day Moving Averages for STML is 15.48. It is 58.93% above current price. The 52-week High is 20.55. It is 110.99% from the current price. The 52-week Low is 7.82. It is -19.71% from current price.

There are some statistics of STML. It is has market cap $309.74 million. The share outstanding is 31.80 million. The average volume is 581816. The percent of top 15 Institution holding is 93.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of STML is -124.14%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of STML is -99.57%.


Tags:

Share this post